Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk.
Addition of a general surgeon without addition of appropriate support is inadequate to improve outcomes of trauma patients in a rural setting: a cohort study of 1962 consecutive patients.
Pros and cons of medical cannabis use by people with chronic brain disorders.
SOX10 Regulates an Alternative Promoter at the Charcot-Marie-Tooth Disease Locus MTMR2.
Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.
A Review of Possible Herbal Treatment in Multiple Sclerosis in Traditional Persian Medicine.
Thickening of the peripheral nerves in metachromatic leukodystrophy.
Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.
Corrigendum to "The-effect-of-triiodothyronine-on-maturation-and-differentiation-of-oligodendrocyte-progenitor-cells-during-remyelination-following-induced-demyelination in male albino rat" [Tissue Cell 48 (March (3)) (2016) 242-251].
Which gait parameter can be used to evaluate gait improvement in multiple sclerosis?
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk.
Metabolic Patterns in Chronic MS Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using Two-Dimensional MR Spectroscopic Imaging.
Magnetic resonance imaging assessment of degenerative cervical myelopathy: a review of structural changes and measurement techniques.
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NFκB.
Assessment of vitamin D status - a changing landscape.
Dysautonomic polyneuropathy as a variant of chronic inflammatory "demyelinating" polyneuropathy?
Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis.
The Pharmacological Effects and Mechanism of Tripterygium wilfordii Hook F in Central Nervous System Autoimmunity.
Lesson of the month 1: Post-malaria neurological syndromes.
Antibodies in multiple sclerosis oligoclonal bands target debris.
[Value of electroencephalography in the early detection of neonatal leucinosis].
Management of Spinal Deformity in Adult Patients With Neuromuscular Disease.
Cognitive motor interference in multiple sclerosis: Insights from a systematic, quantitative review.

Pages